AI Science Tracker
EN

DRCNN-Lesion Proxy: a hybrid CNN with lesion-inspired feature simulation for diabetic retinopathy severity classification.

Not stated in the abstract reviewed · 30 Oct 2025 · medicine

Discovery

DRCNN-Lesion Proxy: a hybrid CNN with lesion-inspired feature simulation for diabetic retinopathy severity classification.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Methods dataset/split §§; Results Tables 8–9 and 15. Hybrid CNN uses lesion-proxy features; pooled EyePACS/Messidor/APTOS split is image-level, not patient-level, leaving leakage risk and external clinical validation unresolved.

Technology: Methods dataset/split §§; Results Tables 8–9 and 15. Hybrid CNN uses lesion-proxy features; pooled EyePACS/Messidor/APTOS split is image-level, not patient-level, leaving leakage risk and external clinical validation unresolved.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods dataset/split §§; Results Tables 8–9 and 15. Hybrid CNN uses lesion-proxy features; pooled EyePACS/Messidor/APTOS split is image-level, not patient-level, leaving leakage risk and external clinical validation unresolved.
Limitation / still unknown
The result is limited to the reported study population, data and evaluation; broader generalization or real-world benefit was not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12575606/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.